MedTrace Logo

Clinical Study on the Efficacy and Safety of Hydromorphone for ICU Analgesia

NCT06848452 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-03-14

No results posted yet for this study

Summary

This study is a prospective, single-center clinical study to evaluate the advantages, extensibility and safety of hydromorphone as an analgesic drug in ICU, and to compare it with remifentanil, a traditional sedative drug. These conclusions can guide us to understand the characteristics of analgesic drugs, carry out appropriate pain management, improve the status of ICU patients, and improve the quality of life of patients.

Conditions

  • Analgesia
  • ICU Patients Requiring Invasive Mechanical Ventilation

Interventions

OTHER

no-intervention

no-intervention

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06848452 on ClinicalTrials.gov